Clinical Trial Update: Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer [Phase 3]

View source ↗

Summary

This document reports on a Phase 3 trial comparing early versus delayed hormone therapy in nonmetastatic prostate cancer. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (unspecified)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Neoplasm, Prostate | Phase 3 | Status: COMPLETED